Fitusiran prophylaxis in male pediatric subjects aged 1 to less than 12 years with hemophilia A or B

Trial Identifier: EFC15467
Sponsor: Genzyme, a Sanofi Company
Start Date: January 2020
Primary Completion Date: August 2026
Study Completion Date: December 2026
Condition: Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CANADA, Ontario Hamilton, Ontario, CANADA, L8N 3Z5
CANADA, Ontario Ottawa, Ontario, CANADA, K1H 8L1
India Mumbai, India, 400 022
India Pune-411011, India, 411 011
India Vellore, India, 632004
INDIA Bangalore, INDIA, 560034
Italy, Not Known Milano, Not Known, Italy, 20122
ITALY, Firenze Firenze, ITALY, 50134
Spain, Madrid, Comunidad de Madrid, Madrid, Comunidad de, Spain, 28046
TURKEY Adana, TURKEY, 01130
TURKEY Istanbul, TURKEY, 34093
TURKEY Izmir, TURKEY, TR-35100
United States, California Los Angeles, California, United States, 90027
United States, New Jersey Hackensack, New Jersey, United States, 07601
United States, Ohio Cleveland, Ohio, United States, 44106
United States, Pennsylvania Hershey, Pennsylvania, United States, 17033